Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics Total Liabilities (Quarterly) : 675.63M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 675.63M |
| September 30, 2025 | 638.39M |
| June 30, 2025 | 611.00M |
| March 31, 2025 | 596.28M |
| December 31, 2024 | 590.99M |
| September 30, 2024 | 607.73M |
| June 30, 2024 | 616.96M |
| March 31, 2024 | 591.10M |
| December 31, 2023 | 617.71M |
| September 30, 2023 | 630.85M |
| June 30, 2023 | 618.51M |
| March 31, 2023 | 597.95M |
| December 31, 2022 | 601.12M |
| September 30, 2022 | 626.96M |
| June 30, 2022 | 627.16M |
| March 31, 2022 | 588.32M |
| December 31, 2021 | 597.77M |
| September 30, 2021 | 580.05M |
| June 30, 2021 | 572.98M |
| March 31, 2021 | 559.14M |
| December 31, 2020 | 600.14M |
| September 30, 2020 | 580.27M |
| June 30, 2020 | 340.50M |
| March 31, 2020 | 335.76M |
| December 31, 2019 | 373.78M |
| Date | Value |
|---|---|
| September 30, 2019 | 334.02M |
| June 30, 2019 | 317.98M |
| March 31, 2019 | 313.03M |
| December 31, 2018 | 447.04M |
| September 30, 2018 | 427.64M |
| June 30, 2018 | 263.99M |
| March 31, 2018 | 348.39M |
| December 31, 2017 | 274.17M |
| September 30, 2017 | 271.10M |
| June 30, 2017 | 672.07M |
| March 31, 2017 | 682.60M |
| December 31, 2016 | 676.69M |
| September 30, 2016 | 581.62M |
| June 30, 2016 | 579.76M |
| March 31, 2016 | 551.28M |
| December 31, 2015 | 560.55M |
| September 30, 2015 | 607.94M |
| June 30, 2015 | 75.01M |
| March 31, 2015 | 88.61M |
| December 31, 2014 | 87.79M |
| September 30, 2014 | 82.21M |
| June 30, 2014 | 81.69M |
| March 31, 2014 | 81.27M |
| December 31, 2013 | 81.81M |
| September 30, 2013 | 42.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 5.402B |
| Insmed, Inc. | 1.345B |
| Ligand Pharmaceuticals, Inc. | 1.218B |
| PTC Therapeutics, Inc. | 3.416B |
| Establishment Labs Holdings, Inc. | 330.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 949.87M |
| Shareholders Equity (Quarterly) | 274.24M |
| Debt to Equity Ratio | 1.613 |
| Current Ratio | 2.843 |
| Net Debt Paydown Yield | 0.01% |